Translational Research and Clinical Trial Study Group, U-Vet Werribee Animal Hospital, Werribee, Victoria, Australia.
Aust Vet J. 2022 Jan;100(1-2):56-62. doi: 10.1111/avj.13127. Epub 2021 Nov 14.
Traditionally, urinary tract infections (UTIs) have been categorised as either uncomplicated or complicated in veterinary medicine, with treatment differing for the two categories. In human medicine, there is an additional category: Asymptomatic bacteriuria, which is the presence of bacteriuria without symptoms of infection. Escherichia coli (E.coli) is the most common bacterial species involved in UTIs in dogs. Clinical signs can be absent in dogs with complicated UTIs, and this has been likened to asymptomatic bacteriuria (ASB) in people and has been termed subclinical bacteriuria (SBU) with the treatment recommendations for SBU in dogs have been adapted from human recommendations. There is a shift in the current treatment of UTIs to help minimise the development of antimicrobial resistance. Routine screening of dogs with conditions that may predispose them to UTIs has been discouraged as has the treatment of SBU. This has been due to the increase in antimicrobial resistance (AMR).
在兽医领域，尿路感染（UTI）通常分为单纯性和复杂性，这两种类型的治疗方法有所不同。在人类医学中，还有另一个类别：无症状菌尿，即存在菌尿而没有感染症状。大肠杆菌（E.coli）是导致犬类 UTI 的最常见细菌种类。患有复杂性 UTI 的犬可能没有临床症状，这类似于人类的无症状菌尿（ASB），并且已经被称为亚临床菌尿（SBU），犬的 SBU 治疗建议已经从人类建议中改编而来。目前正在改变 UTI 的治疗方法，以帮助尽量减少抗菌药物耐药性的发展。已经不鼓励对可能易患 UTI 的犬进行常规筛查，也不鼓励治疗 SBU。这是因为抗菌药物耐药性（AMR）的增加。
